BATM Advanced Communications Ld Further Order for Biopharma Waste Solution (8851P)
23 November 2016 - 6:00PM
UK Regulatory
TIDMBVC
RNS Number : 8851P
BATM Advanced Communications Ld
23 November 2016
23 November 2016
BATM Advanced Communications Limited
("BATM" or "the Group")
Further Order for New Biological Waste Solution from a Leading
Vaccine Producer
Leading manufacturer of vaccines for animal health has ordered
second unit of BATM solution for treatment of hazardous waste for
biopharma industry
BATM Advanced Communications Limited (LSE: BVC), a leading
provider of real-time technologies for networking solutions and
medical laboratory systems, is pleased to announce that its
Pathogenic Waste Treatment and Sterilisation unit of the
Bio-Medical Division has been awarded a second order for its
biological waste solution developed for the biopharmaceutical
industry by one of the world's largest manufacturers of vaccines
for animal health (the "Customer"). This follows the successful
installation and commencement of operation, completed during H2
2016, of an initial unit at a production facility of the Customer,
as noted in the Group's interim results announcement dated 30
August 2016.
This second order, under a contract worth c. US$1.4m, is for a
unit at another facility of the Customer. The Group will receive c.
US$0.8m under the first phase of the installation of the unit, with
delivery commencing immediately and due to be completed in 2017.
The second, and final, phase of the installation is expected to be
completed in 2018. In addition to the c. US$0.3m received during
2016 for the delivery of the first unit, this new order will result
in total sales to the Customer of c. US$1.7m compared to the
Group's initial estimate of US$1.2m.
Ofer Barner, CEO of the Group's Pathogenic Waste Treatment and
Sterilisation and Distribution units, said: "This second order for
our unique instrument from such an established business provides
validation of the strength of our solution for treating biological
waste. This new technology saves on capital expenditure,
manufacturing space and operational costs while reducing the risk
of cross contamination. We believe this endorsement will pave the
way for potential orders from other vaccine producers."
The solution, based on the Group's patented Integrated
Steriliser and Shredder ("ISS") technology, automates the entire
process of disposing of the bio-hazardous waste safely and enables
the treatment of the waste onsite, thereby mitigating the risk of
cross-contamination. The Group's solution does not involve any
environmentally-damaging materials and the treated waste is safe
for humans and the environment.
Dr Zvi Marom, CEO of BATM, added: "We are very pleased to have
received this second order for our biological waste solution for
the biopharma industry. Our ISS technology is already used in more
than 400 medical facilities. Now, the same technology is being
deployed on a much larger scale in the biopharma industry - and by
year-end we expect that a major ISS-based unit will also be fully
operational under an existing contract in the agricultural sector.
This unique solution, applicable to several industries, brings
great cost savings to its users as well as being beneficial for the
environment. We are delighted with the initial demand that we have
received for this technology, and believe that its benefits will be
increasingly recognised by existing and new customers."
Enquiries:
BATM Advanced Communications
--------------------------------- -----------------
Dr Zvi Marom, Chief Executive
Officer +972 9866 2525
--------------------------------- -----------------
Moti Nagar, Chief Financial
Officer
--------------------------------- -----------------
finnCap
--------------------------------- -----------------
Stuart Andrews, Scott Mathieson +44 20 7220 0500
--------------------------------- -----------------
Shore Capital
--------------------------------- -----------------
Mark Percy, Anita Ghanekar +44 20 7408 4090
--------------------------------- -----------------
Luther Pendragon
--------------------------------- -----------------
Harry Chathli, Claire Norbury +44 20 7618 9100
--------------------------------- -----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBTBPTMBATBRF
(END) Dow Jones Newswires
November 23, 2016 02:00 ET (07:00 GMT)
Batm Advanced Communicat... (LSE:BVC)
Historical Stock Chart
From Apr 2024 to May 2024
Batm Advanced Communicat... (LSE:BVC)
Historical Stock Chart
From May 2023 to May 2024